| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. | Clin Cancer Res | 2004 | 0.89 |
| 2 | Histone deacetylase inhibitors for treatment of hepatocellular carcinoma. | Acta Pharmacol Sin | 2005 | 0.88 |
| 3 | Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis. | Eur J Clin Pharmacol | 2010 | 0.83 |
| 4 | Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report. | Pancreas | 2008 | 0.77 |